Dexamethasone induced cardiac hypertrophy in newborn rats is accompanied by changes in myosin heavy chain phenotype and gene transcription

被引:32
作者
Muangmingsuk, S
Ingram, P
Gupta, MP
Arcilla, RA
Gupta, M
机构
[1] Hope Childrens Hosp, Heart Inst Children, Chicago, IL USA
[2] Univ Illinois, Dept Physiol & Biophys, Chicago, IL 60680 USA
[3] Univ Chicago, Dept Cardiac Surg, Chicago, IL 60637 USA
关键词
myosin heavy chain; gene expression; hypertrophy; dexamethasone; promoter function;
D O I
10.1023/A:1007128300430
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Cardiac hypertrophy has been observed in newborn infants treated with dexamethasone (DEX). This study was undertaken to examine whether DEX-induced hypertrophy in newborn rats is associated with redistribution of cardiac myosin heavy chain (MHC) isoforms and if so, the effects involve transcriptional regulation. Newborn rats were injected with either DEX (1 mg/kg/day; s.c.) or equivalent volume normal saline for 1, 3, 5, 7 or 9 days. Hypertrophy was quantified by heart dry/wet wt ratios, heart/body wt ratios, and total protein content of the myocardium. Changes in the expression of cardiac MHC mRNA were characterized by northern blot and slot blot analyses, using isoform specific probes for alpha- and beta-MHC genes. DEX effect on alpha-MHC gene transcription was analyzed by transiently transfecting various alpha-MHC promoter/CAT reporter constructs into primary cultures of cardiac myocytes derived from one day old rat pups. DEX administration into newborn rats produced significant cardiac hypertrophy ranging from 23% at day 1 to 59% at 9 days. The hypertrophy was accompanied by immediate increase (83%) in steady state level of the alpha-MHC mRNA within one day and a maximum increase (148%) at 7 days of treatment. The steady state level of beta-MHC mRNA declined by 25% at day 1 and a maximum decrease of 54% at day 7 of DEX treatment. The changes in MHC mRNA were also reflected in their protein levels as determined by V1 and V3 isozyme analysis. DEX treatment of primary cultures of cardiomyocytes following transfection with a-MHC promoter/CAT reporter constructs resulted in increased CAT expression in a dose dependent manner. The minimum alpha-MHC gene sequences responding to DEX treatment were located between the -200 to -74-bp region of the gene, resulting in 2-fold and 6-fold activation of CAT reporter after 0.05 and 0.1 mM doses of DEX, respectively. Our data indicate that DEX induced cardiac hypertrophy in newborn rats is accompanied by increased expression of alpha-MHC and decreased expression of beta-MHC. The alpha-MHC effects are mediated in part through transcriptional mechanisms.
引用
收藏
页码:165 / 173
页数:9
相关论文
共 46 条
  • [1] ARGENTIN S, 1991, J BIOL CHEM, V266, P23315
  • [2] Bensky AS, 1996, PEDIATRICS, V97, P818
  • [3] BIAN XP, 1992, J DEV PHYSIOL, V18, P35
  • [4] BREM AS, 1995, P SOC EXP BIOL MED, V209, P146
  • [5] BRUNA RD, 1995, J HYPERTENS, V13, P763
  • [6] STEROID-HORMONE REGULATION OF MYOSIN SUBUNIT EXPRESSION IN SMOOTH AND CARDIAC-MUSCLE
    CALOVINI, T
    HAASE, H
    MORANO, I
    [J]. JOURNAL OF CELLULAR BIOCHEMISTRY, 1995, 59 (01) : 69 - 78
  • [7] CHEN CA, 1988, BIOTECHNIQUES, V6, P632
  • [8] ISOLATION OF BIOLOGICALLY-ACTIVE RIBONUCLEIC-ACID FROM SOURCES ENRICHED IN RIBONUCLEASE
    CHIRGWIN, JM
    PRZYBYLA, AE
    MACDONALD, RJ
    RUTTER, WJ
    [J]. BIOCHEMISTRY, 1979, 18 (24) : 5294 - 5299
  • [9] CHIZZONITE RA, 1984, J BIOL CHEM, V259, P2628
  • [10] CLARK AF, 1986, AM J PHYSIOL, V250, pC821, DOI 10.1152/ajpcell.1986.250.6.C821